Pin42 - Determinating the Acceptable Price for Quadrivalent Influenza Vaccine in Russia

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1361
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost-Effectiveness of Quadrivalent Influenza Vaccine for National Immunization Program in South Korea

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Quadrivalent Versus Trivalent Influenza Vaccine: Clinical Outcomes in Two Influenza Seasons, Historical Cohort Study

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2020English

Expected Cost-Utility of Quadrivalent Influenza Vaccine Under a Universal Influenza Immunization Program in Ontario, Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Oral Modeling of an Adenovirus-Based Quadrivalent Influenza Vaccine in Ferrets and Mice

Infectious Diseases and Therapy
Infectious DiseasesMicrobiology
2016English

Rationale for Vaccination With Trivalent or Quadrivalent Live Attenuated Influenza Vaccines: Protective Vaccine Efficacy in the Ferret Model

PLoS ONE
Multidisciplinary
2018English

P367 to Switch or Not to Switch: The Benefit of Quadrivalent Influenza Vaccine to the Irish Paediatric Population

2019English

Promising Quadrivalent, Live-Attenuated Pseudomonas Vaccine

Microbe
Microbiology
2011English

Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccines for Children

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy